Healthcare Industry News: HSMN NewsFeed
News Release - November 1, 2018
Cantel Appoints Bill Haydon to Senior Vice President and General Manager of Medical DivisionLITTLE FALLS, N.J., Nov. 1, 2018 -- (Healthcare Sales & Marketing Network) -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Bill Haydon has been recently appointed to Senior Vice President and General Manager of the Medical division. Mr. Haydon will serve on the Executive Leadership Team and report to Jorgen B. Hansen, President and CEO.
In this role, Mr. Haydon will be responsible for the overall day-to-day operations for the Medical division, including responsibility for the strategic direction, P&L oversight, marketing, and business development.
"Bill is an accomplished leader and an excellent choice to lead our Medical division, as he has already made significant contributions during his time at Cantel," said Jorgen Hansen, President and CEO. "With his broad and deep experience and his diverse set of business and leadership skills, I am confident that Bill will continue the strong trajectory of our Medical division, contributing to the overall growth of our Company."
Mr. Haydon joined Cantel in 2015 as VP, Global Marketing and Business Development, Medical (formerly Endoscopy). Throughout his tenure with the Company and Medical division, Mr. Haydon, as part of a broader team, was instrumental in evolving the global commercial strategy, establishing a robust product pipeline, and leading strategic acquisitions for the Medical division. In addition, he led the development of a global Marketing and Business Development team designed to address the needs of the evolving infection prevention market and its customers.
Prior to joining Cantel, Mr. Haydon held various leadership roles with increasing responsibility for over 20 years at companies including Boston Scientific, Bayer Healthcare, and St. Jude Medical.
Cantel is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
Source: Cantel Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.